Innovations in hematopoietic stem-cell mobilization: A review of the novel CXCR4 inhibitor motixafortide

Authors

Zachary D. Crees, Washington University School of Medicine in St. Louis
Michael P. Rettig, Washington University School of Medicine in St. Louis
John F. DiPersio, Washington University School of Medicine in St. Louis

Journal

Therapeutic Advances in Hematology

Publication Date

1-1-2023

Volume

14

First Page

e20406207231174304

Document Type

Open Access Publication

DOI

10.1177/20406207231174304

Rights and Permissions

Crees ZD, Rettig MP, DiPersio JF. Innovations in hematopoietic stem-cell mobilization: a review of the novel CXCR4 inhibitor motixafortide. Ther Adv Hematol. 2023 May 23;14:20406207231174304. doi: 10.1177/20406207231174304.

Recommended Citation

Crees, Zachary D.; Rettig, Michael P.; and DiPersio, John F., "Innovations in hematopoietic stem-cell mobilization: A review of the novel CXCR4 inhibitor motixafortide." Therapeutic Advances in Hematology. 14, e20406207231174304 (2023).
https://digitalcommons.wustl.edu/oa_4/1880

Department

ICTS (Institute of Clinical and Translational Sciences)